Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What's Pozen Really Worth?
Seeking Alpha
Tuesday, March 8, 2011 - 5:59pm
tags:
Pozen, AstraZeneca, GSK
Apricus Biosciences: Great Pipeline at a Good Price
Seeking Alpha
Tuesday, March 8, 2011 - 11:51am
tags:
Apricus Biosciences, Warner Chilcott
Salix's IBS drug fails to get FDA nod
Reuters
Tuesday, March 8, 2011 - 11:48am
tags:
FDA, Salix, IBS, irritable bowel syndrome, Xifaxan
Sangamo: The Next Pinnacle in HIV Treatment?
Seeking Alpha
Tuesday, March 8, 2011 - 11:45am
tags:
Sangamo BioSciences, HIV
4-Star Stocks Poised to Pop: Isis Pharmaceuticals
Motley Fool
Tuesday, March 8, 2011 - 11:35am
tags:
Isis Pharmaceuticals
J&J Unit Gets U.S. FDA Warning Letter Over Stent Failures
Bloomberg
Tuesday, March 8, 2011 - 11:34am
tags:
warnings, JNJ, stents, Cordis
Catalyst Pharmaceutical to sell 2.26M shares
Bizjournals.com
Tuesday, March 8, 2011 - 11:33am
tags:
Catalyst, stock offering
Abbott’s Kaletra Tied to Risks in Premature Babies, FDA Says
Bloomberg
Tuesday, March 8, 2011 - 11:32am
tags:
FDA, Kaletra, HIV
Teva Says Doctors Contacted on Trial of Generic Copaxone Drug
Bloomberg
Tuesday, March 8, 2011 - 9:37am
tags:
Teva Pharmaceuticals, generics, Copaxone, MS, multiple sclerosis
FDA accepts application for Astra diabetes drug
Yahoo/AP
Tuesday, March 8, 2011 - 9:36am
tags:
FDA, diabetes, Bristol-Myers Squibb, AstraZeneca, Dapagliflozin
J&J’s Animas Recalls Five Lots of Leaking Insulin Cartridges
Bloomberg
Tuesday, March 8, 2011 - 9:00am
tags:
JNJ, recalls, diabetes, insulin, Animas
Gilead Drug Combination Cut Hepatitis Virus in Study, RBC Says
Bloomberg
Tuesday, March 8, 2011 - 7:58am
tags:
Gilead Sciences, hepatitis C
Exelixis Slides on Stock Sale Plans
TheStreet.com
Tuesday, March 8, 2011 - 7:57am
tags:
stock offering, Exelixis
Supreme Court Rejects Challenge To Pay-To-Delay
Pharmalot
Monday, March 7, 2011 - 5:48pm
tags:
Supreme Court, pay-for-delay, Barr Laboratories, Bayer, Cipro, Teva Pharmaceuticals
Jazz 4Q profit surges on sales of Xyrem
Yahoo/AP
Monday, March 7, 2011 - 5:47pm
tags:
Jazz Pharmaceuticals, earnings, Xyrem
Priority Review for CELG Drug
Yahoo/Zacks.com
Monday, March 7, 2011 - 5:24pm
tags:
Celgene, FDA, Istodax, T-cell lymphoma, lymphoma
Scrutinized in Japan, Pfizer’s Prevnar Vaccine is Used Widely in U.S.
WSJ Online
Monday, March 7, 2011 - 5:20pm
tags:
vaccines, Japan, Prevnar, Pfizer
Pfizer Needs Rheumatoid Arthritis Drug to Keep Performing
Seeking Alpha
Monday, March 7, 2011 - 5:18pm
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Genzyme board urges shareholders to accept Sanofi deal
Bizjournals.com
Monday, March 7, 2011 - 5:18pm
tags:
shareholders, Sanofi, Genzyme, M&A
Morphosys' Growth Story Remains Intact
Seeking Alpha
Monday, March 7, 2011 - 11:42am
tags:
MorphoSys, Immunogen, Micromet, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.